牛乳多糖作为细胞毒、抗氧化和降糖药物的生物学效应:体外和体内研究。

IF 4.9 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Aya Maaloul, Claudia Pérez Manríquez, Juan Decara, Manuel Marí-Beffa, Daniel Álvarez-Torres, Sofía Latorre Redoli, Borja Martínez-Albardonedo, Marisel Araya-Rojas, Víctor Fajardo, Roberto T Abdala Díaz
{"title":"牛乳多糖作为细胞毒、抗氧化和降糖药物的生物学效应:体外和体内研究。","authors":"Aya Maaloul, Claudia Pérez Manríquez, Juan Decara, Manuel Marí-Beffa, Daniel Álvarez-Torres, Sofía Latorre Redoli, Borja Martínez-Albardonedo, Marisel Araya-Rojas, Víctor Fajardo, Roberto T Abdala Díaz","doi":"10.3390/pharmaceutics17030335","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: This study explores the bioactive potential of <i>Bovistella utriformis</i> biomass and its polysaccharides (PsBu) through comprehensive biochemical and bioactivity analyses, focusing on their antioxidant, cytotoxic, and antihyperglycemic properties. <b>Methods</b>: Elemental analysis determined the biomass's chemical composition. Antioxidant activity was assessed using ABTS and DPPH assays. Monosaccharide composition was analyzed via gas chromatography-mass spectrometry (GC-MS). In vitro cytotoxicity assays were conducted on cancer and normal cell lines to determine IC<sub>50</sub> values and selectivity indices (SI). Zebrafish embryo toxicity was evaluated for teratogenic effects, and an in vivo antihyperglycemic study was performed in diabetic rat models. <b>Results</b>: The biomass exhibited high carbon content (around 41%) and nitrogen levels, with a balanced C/N ratio nearing 5. Protein content exceeded 50%, alongside significant carbohydrate, fiber, and ash levels. Antioxidant assays revealed inhibition rates of approximately 89% (ABTS) and 64% (DPPH). GC-MS analysis identified glucose as the predominant sugar (>80%), followed by galactose and mannose. Additionally, HPLC detected a photoprotective compound, potentially a mycosporin-like amino acid. Cytotoxicity assays demonstrated PsBu's selective activity against colon, lung, and melanoma cancer cell lines (IC<sub>50</sub>: 100-500 µg·mL<sup>-1</sup>), while effects on normal cell lines were lower (IC<sub>50</sub> > 1300 µg·mL<sup>-1</sup> for HaCaT, >2500 µg·mL<sup>-1</sup> for HGF-1), with SI values approaching 27, supporting PsBu's potential as a targeted anticancer agent. Zebrafish embryo assays yielded LC<sub>50</sub> values ranging from 1.4 to 1.8 mg·mL<sup>-1</sup>. In vivo, PsBu reduced fasting blood glucose levels in hyperglycemic rats (approximately 210 mg·dL<sup>-1</sup> vs. 230 mg·dL<sup>-1</sup> in controls) and preserved pancreatic β-cell integrity (around 80% vs. 65% in controls). <b>Conclusions</b>: These findings suggest that <i>B. utriformis</i> biomass and PsBu exhibit strong antioxidant activity, selective cytotoxicity against cancer cells, and antihyperglycemic potential, making them promising candidates for further biomedical applications.</p>","PeriodicalId":19894,"journal":{"name":"Pharmaceutics","volume":"17 3","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11946522/pdf/","citationCount":"0","resultStr":"{\"title\":\"Biological Effects of Polysaccharides from <i>Bovistella utriformis</i> as Cytotoxic, Antioxidant, and Antihyperglycemic Agents: In Vitro and In Vivo Studies.\",\"authors\":\"Aya Maaloul, Claudia Pérez Manríquez, Juan Decara, Manuel Marí-Beffa, Daniel Álvarez-Torres, Sofía Latorre Redoli, Borja Martínez-Albardonedo, Marisel Araya-Rojas, Víctor Fajardo, Roberto T Abdala Díaz\",\"doi\":\"10.3390/pharmaceutics17030335\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background/Objectives</b>: This study explores the bioactive potential of <i>Bovistella utriformis</i> biomass and its polysaccharides (PsBu) through comprehensive biochemical and bioactivity analyses, focusing on their antioxidant, cytotoxic, and antihyperglycemic properties. <b>Methods</b>: Elemental analysis determined the biomass's chemical composition. Antioxidant activity was assessed using ABTS and DPPH assays. Monosaccharide composition was analyzed via gas chromatography-mass spectrometry (GC-MS). In vitro cytotoxicity assays were conducted on cancer and normal cell lines to determine IC<sub>50</sub> values and selectivity indices (SI). Zebrafish embryo toxicity was evaluated for teratogenic effects, and an in vivo antihyperglycemic study was performed in diabetic rat models. <b>Results</b>: The biomass exhibited high carbon content (around 41%) and nitrogen levels, with a balanced C/N ratio nearing 5. Protein content exceeded 50%, alongside significant carbohydrate, fiber, and ash levels. Antioxidant assays revealed inhibition rates of approximately 89% (ABTS) and 64% (DPPH). GC-MS analysis identified glucose as the predominant sugar (>80%), followed by galactose and mannose. Additionally, HPLC detected a photoprotective compound, potentially a mycosporin-like amino acid. Cytotoxicity assays demonstrated PsBu's selective activity against colon, lung, and melanoma cancer cell lines (IC<sub>50</sub>: 100-500 µg·mL<sup>-1</sup>), while effects on normal cell lines were lower (IC<sub>50</sub> > 1300 µg·mL<sup>-1</sup> for HaCaT, >2500 µg·mL<sup>-1</sup> for HGF-1), with SI values approaching 27, supporting PsBu's potential as a targeted anticancer agent. Zebrafish embryo assays yielded LC<sub>50</sub> values ranging from 1.4 to 1.8 mg·mL<sup>-1</sup>. In vivo, PsBu reduced fasting blood glucose levels in hyperglycemic rats (approximately 210 mg·dL<sup>-1</sup> vs. 230 mg·dL<sup>-1</sup> in controls) and preserved pancreatic β-cell integrity (around 80% vs. 65% in controls). <b>Conclusions</b>: These findings suggest that <i>B. utriformis</i> biomass and PsBu exhibit strong antioxidant activity, selective cytotoxicity against cancer cells, and antihyperglycemic potential, making them promising candidates for further biomedical applications.</p>\",\"PeriodicalId\":19894,\"journal\":{\"name\":\"Pharmaceutics\",\"volume\":\"17 3\",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11946522/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/pharmaceutics17030335\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/pharmaceutics17030335","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:本研究通过综合生化和生物活性分析,探讨牛乳多糖(PsBu)的生物活性潜力,重点研究其抗氧化、细胞毒和降糖特性。方法:元素分析测定生物质化学成分。采用ABTS和DPPH测定抗氧化活性。采用气相色谱-质谱(GC-MS)分析单糖组成。对肿瘤和正常细胞株进行体外细胞毒性测定,测定IC50值和选择性指数(SI)。对斑马鱼胚胎毒性进行了致畸作用评估,并在糖尿病大鼠模型中进行了体内抗高血糖研究。结果:生物量碳含量高(约41%),氮含量高,碳氮比接近5。蛋白质含量超过50%,同时碳水化合物、纤维和灰分含量也很高。抗氧化实验显示其抑制率约为89% (ABTS)和64% (DPPH)。GC-MS分析发现葡萄糖是主要的糖(bbb80 %),其次是半乳糖和甘露糖。此外,HPLC检测到一种光保护化合物,可能是一种类似真菌素的氨基酸。细胞毒性试验表明,PsBu对结肠癌、肺癌和黑色素瘤细胞系具有选择性活性(IC50: 100-500µg·mL-1),而对正常细胞系的作用较低(HaCaT的IC50: 1300µg·mL-1, HGF-1的IC50: 2500µg·mL-1), SI值接近27,支持PsBu作为靶向抗癌剂的潜力。斑马鱼胚胎测定的LC50值为1.4 ~ 1.8 mg·mL-1。在体内,PsBu降低了高血糖大鼠的空腹血糖水平(约210 mg·dL-1,对照组为230 mg·dL-1),并保持了胰腺β细胞的完整性(约80%,对照组为65%)。结论:这些发现表明,营养双翼菌生物量和PsBu具有较强的抗氧化活性,对癌细胞具有选择性的细胞毒性和降糖潜力,具有进一步的生物医学应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Biological Effects of Polysaccharides from Bovistella utriformis as Cytotoxic, Antioxidant, and Antihyperglycemic Agents: In Vitro and In Vivo Studies.

Background/Objectives: This study explores the bioactive potential of Bovistella utriformis biomass and its polysaccharides (PsBu) through comprehensive biochemical and bioactivity analyses, focusing on their antioxidant, cytotoxic, and antihyperglycemic properties. Methods: Elemental analysis determined the biomass's chemical composition. Antioxidant activity was assessed using ABTS and DPPH assays. Monosaccharide composition was analyzed via gas chromatography-mass spectrometry (GC-MS). In vitro cytotoxicity assays were conducted on cancer and normal cell lines to determine IC50 values and selectivity indices (SI). Zebrafish embryo toxicity was evaluated for teratogenic effects, and an in vivo antihyperglycemic study was performed in diabetic rat models. Results: The biomass exhibited high carbon content (around 41%) and nitrogen levels, with a balanced C/N ratio nearing 5. Protein content exceeded 50%, alongside significant carbohydrate, fiber, and ash levels. Antioxidant assays revealed inhibition rates of approximately 89% (ABTS) and 64% (DPPH). GC-MS analysis identified glucose as the predominant sugar (>80%), followed by galactose and mannose. Additionally, HPLC detected a photoprotective compound, potentially a mycosporin-like amino acid. Cytotoxicity assays demonstrated PsBu's selective activity against colon, lung, and melanoma cancer cell lines (IC50: 100-500 µg·mL-1), while effects on normal cell lines were lower (IC50 > 1300 µg·mL-1 for HaCaT, >2500 µg·mL-1 for HGF-1), with SI values approaching 27, supporting PsBu's potential as a targeted anticancer agent. Zebrafish embryo assays yielded LC50 values ranging from 1.4 to 1.8 mg·mL-1. In vivo, PsBu reduced fasting blood glucose levels in hyperglycemic rats (approximately 210 mg·dL-1 vs. 230 mg·dL-1 in controls) and preserved pancreatic β-cell integrity (around 80% vs. 65% in controls). Conclusions: These findings suggest that B. utriformis biomass and PsBu exhibit strong antioxidant activity, selective cytotoxicity against cancer cells, and antihyperglycemic potential, making them promising candidates for further biomedical applications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmaceutics
Pharmaceutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.90
自引率
11.10%
发文量
2379
审稿时长
16.41 days
期刊介绍: Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. It publishes reviews, regular research papers, communications,  and short notes. Covered topics include pharmacokinetics, toxicokinetics, pharmacodynamics, pharmacogenetics and pharmacogenomics, and pharmaceutical formulation. Our aim is to encourage scientists to publish their experimental and theoretical details in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信